A. Lovett-racke

发表

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

J. Paul Robinson, Jonathan A. Rebhahn, Kylie M. Quinn, 2019, European journal of immunology.

Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis

E. Frohman, A. Lovett-racke, R. Stuart, 2007, Journal of Neuroimmunology.

Developmentally regulated gene expression of Th2 cytokines in the brain

A. Lovett-racke, M. Racke, T. Forsthuber, 2000, Brain Research.

Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

Martin Röcken, Susanne Feil, Robert Feil, 2012 .

Novel therapeutic strategies targeting the pathogenic T-cells in multiple sclerosis

A. Lovett-racke, M. Racke, Mark T Muir, 2005, Expert review of clinical immunology.

Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis.

A. Lovett-racke, M. Racke, P. D. Drew, 2002, Journal of immunology.

Treatment of Experimental Autoimmune Encephalomyelitis by Codelivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles

Yuhong Yang, K. Ainslie, A. Lovett-racke, 2014, Molecular pharmaceutics.

Ligands for the peroxisome proliferator-activated receptor-γ and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis

A. Lovett-racke, M. Racke, P. D. Drew, 2004, Journal of Neuroimmunology.

B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients

Yuhong Yang, A. Lovett-racke, M. Racke, 2019, Journal of Neuroimmunology.

Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?

A. Lovett-racke, S. Gombash, P. Lee, 2022, Frontiers in Neurology.

Neuron-Specific Vitamin D Signaling Attenuates Microglia Activation and CNS Autoimmunity

Yuhong Yang, A. Lovett-racke, P. Lee, 2020, Frontiers in Neurology.

A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis

M. Inglese, S. Cocozza, A. Lovett-racke, 2020, Multiple sclerosis.

Alterations of the gut mycobiome in patients with MS

L. Piccio, A. Cross, Yanjiao Zhou, 2021, EBioMedicine.

The Role of Growth Factors in Experimental Autoimmune Encephalomyelitis

A. Lovett-racke, M. Racke, 2005 .

Distinct roles for Blimp-1 in autoreactive CD4 T cells during priming and effector phase of autoimmune encephalomyelitis

Yuhong Yang, A. Lovett-racke, M. Racke, 2018, Journal of Neuroimmunology.

The mechanism of action of glatiramer acetate treatment in multiple sclerosis

A. Lovett-racke, M. Racke, N. Karandikar, 2010, Neurology.

What are new therapies teaching us about the immunology of multiple sclerosis

A. Lovett-racke, M. Racke, 2008 .

CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease

Kathryn J. Jones, A. Lovett-racke, V. Sanders, 2015, Journal of Neuroimmune Pharmacology.

Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.

E. Frohman, A. Lovett-racke, M. Racke, 2008, Clinical immunology.

CD28−CD57+ T cells predominate in CD8 responses to glatiramer acetate

A. Lovett-racke, M. Racke, N. Karandikar, 2006, Journal of Neuroimmunology.

Guidelines for the use of flow cytometry and cell sorting in immunological studies.

J. Paul Robinson, Jonathan A. Rebhahn, B. Becher, 2017, European journal of immunology.

Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravis

P. Christadoss, A. Lovett-racke, M. Racke, 2003, Journal of Neuroimmunology.

The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice

A. Lash, D. McTigue, Akshata A Almad, 2011, Experimental Neurology.

Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease.

A. Lovett-racke, M. Racke, P. D. Drew, 2004, Journal of immunology.

Retrovirus mediated gene transfer of the self antigen MBP into the bone marrow of mice alters resistance to experimental autoimmune encephalomyelitis

T. R. Peters, D. McFarlin, H. McFarland, 2000, Journal of Neuroimmunology.

Increased miR-29b in the aged brain correlates with the reduction of IGF-1 and CX 3 CL1

A. Lovett-racke, J. Godbout, A. Fenn, 2013 .

Sclerosis: An Immunological Perspective Glatiramer Acetate Treatment of Multiple

A. Lovett-racke, M. Racke, 2011 .

Phenotypic characterization of autoreactive T cells in multiple sclerosis

A. Lovett-racke, M. Racke, N. Karandikar, 2006, Journal of Neuroimmunology.

Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells.

A. Lovett-racke, M. Racke, 2002, Cellular immunology.

Autonomic Regulation of Neuroimmunological Responses: Implications for Multiple Sclerosis

E. Frohman, A. Lovett-racke, M. Racke, 2001, Journal of Clinical Immunology.

-Prostaglandin J2 Ameliorates Experimental Autoimmune Encephalomyelitis

A. Lovett-racke, M. Racke, P. D. Drew, 2002 .

Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis.

A. Lovett-racke, M. Racke, P. D. Drew, 2006, The Journal of nutrition.

Memory B cells from a subset of treatment naïve relapsing remitting multiple sclerosis patients elicit CD4+ T cell proliferation and IFN-γ production in response to MBP and MOG

Greenberg, L. Cowell, L. Davis, 2011 .

Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs

Yuhong Yang, A. Lovett-racke, M. Racke, 2010, PPAR research.

Regulation of autoreactive CD4 T cells by FoxO1 signaling in CNS autoimmunity

Yuhong Yang, A. Lovett-racke, E. Kraus, 2021, Journal of Neuroimmunology.

AB0050 Estrogen-Regulated STAT1 Activation Promotes TLR8 Overexpression and Facilitates Mirokine Signaling Via Exosomes Containing MIR-21 Endogenous Ligand: A Novel Innate Inflammatory Pathway in Systemic Lupus Erythematosus

C. Burd, A. Lovett-racke, W. Jarjour, 2015 .

Silencing IFN-γ Binding/Signaling in Astrocytes versus Microglia Leads to Opposite Effects on Central Nervous System Autoimmunity

A. Lovett-racke, Guang-Xian Zhang, A. Rostami, 2015, The Journal of Immunology.

This information is current as Autoimmunity Opposite Effects on Central Nervous System Astrocytes versus Microglia Leads to Binding / Signaling in γ Silencing IFN -

A. Lovett-racke, Guang-Xian Zhang, A. Rostami, 2015 .

Contribution of EAE to understanding and treating multiple sclerosis

A. Lovett-racke, 2017, Journal of Neuroimmunology.

Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder

S. Galetta, L. Steinman, S. Zamvil, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Differential requirements of naïve and memory T cells for CD28 costimulation in autoimmune pathogenesis.

A. Lovett-racke, M. Racke, P. Perrin, 1999, Histology and histopathology.

Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3).

A. Cross, A. Lovett-racke, M. Racke, 1998 .

Agonists as Therapy for Autoimmune a Peroxisome Proliferator-Activated Receptor

A. Lovett-racke, M. Racke, P. D. Drew, 2004 .

Role of nerve growth factor in experimental autoimmune encephalomyelitis

D. Holtzman, A. Lovett-racke, M. Racke, 2001, European journal of immunology.

Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesity

S. Brethauer, K. Wyne, B. Needleman, 2022, Nature Communications.

MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.

Yuhong Yang, A. Lovett-racke, M. Racke, 2016, Brain : a journal of neurology.

Analysis of miRNA in Normal Appearing White Matter to Identify Altered CNS Pathways in Multiple Sclerosis.

D. Pitt, A. Lovett-racke, M. Racke, 2015, Journal of autoimmune disorders.

Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity.

S. Lawler, J. Godlewski, A. Lovett-racke, 2011, Brain : a journal of neurology.

Suppression of Inflammatory Demyelinaton and Axon Degeneration through Inhibiting Kv3 Channels

A. Lovett-racke, P. Jukkola, Yuanzheng Gu, 2017, Front. Mol. Neurosci..

Novel small molecule IL‐6 inhibitor suppresses autoreactive Th17 development and promotes Treg development

Y. Yang, Yuhong Yang, A. Lovett-racke, 2019, Clinical and experimental immunology.

Glatiramer Acetate Treatment of Multiple Sclerosis: An Immunological Perspective

A. Lovett-racke, M. Racke, 2011, The Journal of Immunology.

miRNA profiling for biomarker discovery in multiple sclerosis: From microarray to deep sequencing

H. Alder, A. Lovett-racke, H. Ozer, 2012, Journal of Neuroimmunology.

Analysis of TGF-β1 and TGF-β3 as regulators of encephalitogenic Th17 cells: Implications for multiple sclerosis

Yuhong Yang, A. Lovett-racke, M. Racke, 2015, Brain, Behavior, and Immunity.

Peroxisome Proliferator-Activated Receptor-γ Agonist 15-Deoxy-Δ12,1412,14-Prostaglandin J2 Ameliorates Experimental Autoimmune Encephalomyelitis1

A. Lovett-racke, M. Racke, Bounleut Phanavanh, 2002, The Journal of Immunology.

miRNAs in multiple sclerosis: Regulating the regulators

A. Lovett-racke, M. Racke, M. Guerau-de-Arellano, 2010, Journal of Neuroimmunology.

miR-29ab1 Deficiency Identifies a Negative Feedback Loop Controlling Th1 Bias That Is Dysregulated in Multiple Sclerosis

C. Croce, S. Costinean, A. Bottoni, 2012, The Journal of Immunology.

IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity.

Yuhong Yang, A. Smith, A. Lovett-racke, 2017, JCI insight.

Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity

James A. Thomas, A. Lovett-racke, M. Racke, 2006, Journal of Neuroimmunology.

Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.

R. Koup, D. Douek, J. Brenchley, 2002, The Journal of clinical investigation.

T-bet Regulates the Fate of Th1 and Th17 Lymphocytes in Autoimmunity1

A. Lovett-racke, M. Racke, Rehana Z. Hussain, 2007, The Journal of Immunology.

Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction of experimental autoimmune encephalomyelitis

A. Smith, A. Lovett-racke, M. Racke, 2011, Journal of Neuroimmunology.

Regulation of Experimental Autoimmune Encephalomyelitis with Insulin-like Growth Factor ( IGF-1 ) and IGF-1 / IGF – binding Protein-3 Complex ( IGF-1 / IGFBP 3 )

A. Cross, A. Lovett-racke, M. Racke, 1998 .

Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes.

A. Lovett-racke, M. Racke, D. Sikder, 2004, Immunity.

Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?

Yuhong Yang, A. Lovett-racke, M. Racke, 2011, Biochimica et biophysica acta.

B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report

Yuhong Yang, A. Lovett-racke, M. Racke, 2021, Journal of Neuroimmunology.

T-bet is essential for encephalitogenicity of both Th1 and Th17 cells

Yuhong Yang, A. Smith, A. Lovett-racke, 2009, The Journal of experimental medicine.

Alterations of host-gut microbiome interactions in multiple sclerosis

L. Piccio, A. Cross, Yanjiao Zhou, 2022, EBioMedicine.

IL-3 Is a Marker of Encephalitogenic T Cells, but Not Essential for CNS Autoimmunity

Yuhong Yang, A. Lovett-racke, W. Pei, 2018, Frontiers in Immunology.

Dysregulated in Multiple Sclerosis Feedback Loop Controlling Th1 Bias That Is miR-29ab1 Deficiency Identifies a Negative

C. Croce, A. Bottoni, A. Satoskar, 2012 .

Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling

L. Stitz, B. Hemmer, Wei Hu, 2010, Brain : a journal of neurology.

Expression of the Tyrosine Phosphatase Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase 1 Determines T Cell Activation Threshold and Severity of Experimental Autoimmune Encephalomyelitis1

E. Ward, A. Minguela, C. Radu, 2002, The Journal of Immunology.

The Role of Costimulation in Experimental Autoimmune Encephalomyelitis

A. Lovett-racke, R. Stuart, M. Racke, 2005 .

The role of costimulation in autoimmune demyelination

A. Lovett-racke, M. Racke, P. Perrin, 2000, Journal of Neuroimmunology.

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients

P. Perrin, C. June, A. Lovett-racke, 1998, Journal of Neuroimmunology.

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

C. June, A. Lovett-racke, M. Racke, 1998 .

TGF-β Enhances Effector Th1 Cell Activation but Promotes Self-Regulation via IL-10

Yuhong Yang, A. Lovett-racke, M. Racke, 2010, The Journal of Immunology.

Role of IL-12/IL-23 in the Pathogenesis of Multiple Sclerosis

Yuhong Yang, A. Lovett-racke, M. Racke, 2011 .

TGF‐β signaling via Smad4 drives IL‐10 production in effector Th1 cells and reduces T‐cell trafficking in EAE

Yuhong Yang, A. Lovett-racke, M. Racke, 2011, European journal of immunology.

TGF‐β regulation of encephalitogenic and regulatory T cells in multiple sclerosis

A. Lovett-racke, P. Lee, M. Severin, 2017, European journal of immunology.

T-bet: A Critical Regulator of Encephalitogenic T Cells

A. Lovett-racke, M. Racke, 2013 .

Transcriptional Modulation of the Immune Response by Peroxisome Proliferator-Activated Receptor-α Agonists in Autoimmune Disease1

Yuhong Yang, O. Stuve, A. Lovett-racke, 2009, The Journal of Immunology.

Peroxisome Proliferator-Activated Receptor α Agonists as Therapy for Autoimmune Disease1

A. Lovett-racke, M. Racke, Rehana Z. Hussain, 2004, The Journal of Immunology.

Longitudinal study of myelin basic protein-specific T-cell receptors during the course of multiple sclerosis

U. Utz, Roland Martin, H. McFarland, 1997, Journal of Neuroimmunology.

A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance

Yuhong Yang, A. Lovett-racke, M. Racke, 2021, JCI insight.

Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα

Jian Zhang, A. Lovett-racke, M. Racke, 2016, Journal of Neuroinflammation.

Impact of suppressing retinoic acid‐related orphan receptor gamma t (ROR)γt in ameliorating central nervous system autoimmunity

Y. Liu, M. Larson, Y. Yang, 2015, Clinical and experimental immunology.

CD28:B7 interaction is necessary for the protective effect of T cell vaccination in EAE

Yuhong Yang, A. Lovett-racke, M. Racke, 2007, European journal of immunology.

PTX cruiser: driving autoimmunity via TLR4.

Wei Hu, A. Lovett-racke, M. Racke, 2005, Trends in immunology.

The role of CTLA-4 in tolerance induction and ttigen administration cell differentiation in experimental autoimmune encephalomyelitis: i. v. antigen administration.

A. Lovett-racke, M. Racke, P. Perrin, 1999, International immunology.

The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.p. antigen administration.

A. Lovett-racke, M. Racke, P. Perrin, 1999, International immunology.

Bystander suppression in experimental autoimmune encephalomyelitis: where and how does it occur?

A. Lovett-racke, M. Racke, 1998, Research in immunology.

Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions.

H. Hartung, B. Hemmer, C. Marra, 2007, Archives of neurology.

Therapeutic Potential of Small Interfering RNA for Brain Diseases

A. Lovett-racke, 2009 .

Therapeutic potential of small interfering RNA for central nervous system diseases.

A. Lovett-racke, M. Racke, O. Stüve, 2005, Archives of neurology.

Memory B cells from a subset of treatment‐naïve relapsing‐remitting multiple sclerosis patients elicit CD4+ T‐cell proliferation and IFN‐γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein

Nitin J. Karandikar, L. Cowell, L. Davis, 2010, European journal of immunology.

Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling*

Yuhong Yang, V. Mehta, A. Lovett-racke, 2012, The Journal of Biological Chemistry.

Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages

C. Marsh, A. Lovett-racke, L. Schlesinger, 2016, Autophagy.

Monoclonal antibody therapies and neurologic disorders.

A. Lovett-racke, M. Racke, Michael K Racke, 2008, Archives of neurology.

Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα

Yuhong Yang, Jian Zhang, A. Lovett-racke, 2016, Journal of Neuroinflammation.

K+ channel alterations in the progression of experimental autoimmune encephalomyelitis

S. Zamvil, A. Lovett-racke, P. Jukkola, 2012, Neurobiology of Disease.

Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand

A. Lovett-racke, J. Godbout, A. Fenn, 2013, Neurobiology of Aging.

6 Month Results of a Phase 2a Multicenter Study of Ublituximab, a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Relapsing Multiple Sclerosis

A. Lovett-racke, M. Racke, W. Su, 2018 .

Preliminary results of Phase 2 Multicenter Study of Ublituximab (UTX), a novel glycoengineered anti-CD20 monoclonal antibody (mAb), in patients with relapsing forms of Multiple Sclerosis (RMS) demonstrates rapid and robust B cell depletion (P6.348)

A. Lovett-racke, M. Racke, W. Su, 2017 .

Epstein-Barr virus and multiple sclerosis.

A. Lovett-racke, M. Racke, 2006, Archives of neurology.

Silencing Nogo‐A promotes functional recovery in demyelinating disease

D. McTigue, Yuhong Yang, A. Lovett-racke, 2010, Annals of neurology.

Estrogen-regulated STAT1 activation promotes TLR8 expression to facilitate signaling via microRNA-21 in systemic lupus erythematosus.

M. Bruss, C. Burd, A. Lovett-racke, 2017, Clinical immunology.

PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis

Yuhong Yang, A. Lovett-racke, M. Racke, 2008, PPAR research.

CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease

A. Lovett-racke, V. Sanders, Kathryn J Jones, 2015, Journal of Neuroimmune Pharmacology.

This information is current as Sclerosis : An Immunological Perspective Glatiramer Acetate Treatment of Multiple

A. Lovett-racke, M. Racke, 2011 .

Guidelines for the use of flow cytometry and cell sorting in immunological studies.

J. Paul Robinson, Jonathan A. Rebhahn, B. Becher, 2017, European journal of immunology.

Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF binding protein-3 complex

A. Cross, A. Lovett-racke, M. Racke, 1998, Journal of Neuroimmunology.

Impact of suppressing retinoic acid‐related orphan receptor gamma t (ROR)γt in ameliorating central nervous system autoimmunity

M. Larson, A. Lovett-racke, M. Racke, 2015, Clinical and experimental immunology.

Transcriptional Modulation of the Immune Response by Peroxisome Proliferator-Activated Receptor-α Agonists in Autoimmune Disease1

Yuhong Yang, O. Stuve, A. Lovett-racke, 2009, The Journal of Immunology.

IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity.

Yuhong Yang, A. Smith, A. Lovett-racke, 2017, JCI insight.

Novel therapeutic strategies targeting the pathogenic T-cells in multiple sclerosis

A. Lovett-racke, M. Racke, Mark T Muir, 2005, Expert review of clinical immunology.

Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling*

Yuhong Yang, V. Mehta, A. Lovett-racke, 2012, The Journal of Biological Chemistry.

Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

R. Feil, E. Alexander, A. Lovett-racke, 2011, The Journal of experimental medicine.

T-bet is essential for encephalitogenicity of both Th1 and Th17 cells

Yuhong Yang, A. Smith, A. Lovett-racke, 2009, The Journal of experimental medicine.

Is T-bet a potential therapeutic target in multiple sclerosis?

Yuhong Yang, A. Lovett-racke, M. Racke, 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

MicroRNAs targeting TGF‐β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function

A. Lovett-racke, Yue Liu, Christina N. Rau, 2024, European journal of immunology.